Stock Events

Stock Events

Novo Nordisk 

M$822.94
20460
+M$2.94+0.36% Monday 14:58

Statistics

Day High
822.94
Day Low
822.94
52W High
1,179.99
52W Low
630
Volume
5
Avg. Volume
192
Mkt Cap
3.64T
P/E Ratio
-
Dividend Yield
3.88%
Dividend
31.93

Upcoming

Dividends

3.88%Dividend Yield
Aug 26
M$9.90
Mar 26
M$22.03
Aug 25
M$11.01
Apr 25
M$23.24
Aug 24
M$9.71
10Y Growth
6.93%
5Y Growth
16.31%
3Y Growth
20.65%
1Y Growth
-6.76%

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
13
14.85
16.69
18.54
Expected EPS
13.004729875601997
Actual EPS
N/A

Financials

33.18%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
899.33BRevenue
298.4BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NOVOBN.MX. It's not an investment recommendation.
Microsoft
3726
MSFT
NVIDIA
3509
NVDA
Alphabet
2844
GOOGL
Amazon
2841
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sanofi
SNY
Mkt Cap106.01B
Sanofi competes directly with Novo Nordisk in the diabetes and insulin markets, offering similar products and therapies.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly is a major competitor in the diabetes care market, particularly in insulin and GLP-1 receptor agonists, directly competing with Novo Nordisk's portfolio.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes in the diabetes sector with its range of type 2 diabetes medications, posing competition to Novo Nordisk's diabetes care products.
Merck
MRK
Mkt Cap370.89B
Merck is a competitor in the diabetes market with its drug Januvia among others, competing with Novo Nordisk's diabetes management products.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb competes in the area of diabetes and cardiovascular diseases, areas where Novo Nordisk also has a significant presence.
Pfizer
PFE
Mkt Cap162.16B
Pfizer competes with Novo Nordisk in various therapeutic areas, including chronic diseases, though not as directly in diabetes.
Novartis
NVS
Mkt Cap304.1B
Novartis competes across a broad range of therapeutic areas including cardiovascular, which overlaps with Novo Nordisk's interests.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in several areas including diabetes care.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories competes with Novo Nordisk in the broader healthcare market, including diabetes management through its glucose monitoring devices.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific competes indirectly by providing instruments and reagents for diabetes research, affecting the market landscape.

About

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Show more...
CEO
Maziar Mike Doustdar
Employees
69500
Country
Denmark
ISIN
DK0062498333
WKN
000A3EU6F

Listings

WA
PL
NVO.WA
MX
MX
NOVOBN.MX
LSE
GB
0TDD.LSE
MU
DE
NOVA.MU

0 Comments

Share your thoughts

FAQ

What is Novo Nordisk stock price today?▼
The current price of NOVOBN.MX is M$822.94 MXN — it has increased by +0.36% in the past 24 hours. Watch Novo Nordisk stock price performance more closely on the chart.
What is Novo Nordisk stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange Novo Nordisk stocks are traded under the ticker NOVOBN.MX.
Is Novo Nordisk stock price growing?▼
NOVOBN.MX stock has risen by +1.39% compared to the previous week, the month change is a +1.6% rise, over the last year Novo Nordisk has showed a -24.01% decrease.
What is Novo Nordisk market cap?▼
Today Novo Nordisk has the market capitalization of 3.64T
When is the next Novo Nordisk earnings date?▼
Novo Nordisk is going to release the next earnings report on November 04, 2026.
What were Novo Nordisk earnings last quarter?▼
NOVOBN.MX earnings for the last quarter are 16.24 MXN per share, whereas the estimation was 13.22 MXN resulting in a +22.86% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Novo Nordisk revenue for the last year?▼
Novo Nordisk revenue for the last year amounts to 899.33B MXN.
What is Novo Nordisk net income for the last year?▼
NOVOBN.MX net income for the last year is 298.4B MXN.
Does Novo Nordisk pay dividends?▼
Yes, NOVOBN.MX dividends are paid semi-annual. The last dividend per share was 9.9 MXN. As of today, Dividend Yield (FWD)% is 3.88%.
How many employees does Novo Nordisk have?▼
As of September 08, 2026, the company has 69,500 employees.
In which sector is Novo Nordisk located?▼
Novo Nordisk operates in the Health & Wellness sector.
When did Novo Nordisk complete a stock split?▼
The last stock split for Novo Nordisk was on September 13, 2023 with a ratio of 2:1.
Where is Novo Nordisk headquartered?▼
Novo Nordisk is headquartered in Bagsvaerd, Denmark.